Apollon Formularies Plc - Notice of AGM

05 December 2023

Apollon Formularies Plc

("Apollon" or the "Company")

Notice of AGM

Apollon Formularies plc (AQSE: APOL) announces that notice of its Annual General Meeting ('AGM') has been posted to shareholders, and will shortly be available at the Company website on  https://www.apollon.org.uk/. The AGM will be held on 29 December 2023 at 11am, at 6 Heddon Street, London W1B 4BT.  

The directors of the Company accept responsibility for the contents of this announcement.

ENDS

For additional information, please visit www.apollon.org.uk or contact:

Apollon Formularies                                                     

Tel:                                         +44 771 198 0221

Stene Jacobs                      stene@apollon.org.uk

Peterhouse Capital Limited (Corporate Adviser)               

Tel:                                         +44 207 220 9795

Guy Miller                           gm@peterhousecapital.com

About Apollon and Apollon Jamaica

Apollon Formularies plc is an international medical cannabis and medicinal mushroom pharmaceutical company headquartered in the United Kingdom. Apollon Formularies Jamaica Limited is a pharmaceutical company incorporated and operating in the Commonwealth of Jamaica since 2016. Apollon Jamaica is licensed by the Jamaican government's Cannabis Licensing Authority (CLA) to cultivate (R&D), perform research and development, process, and sell medical cannabis therapeutic products that include legal medical cannabis to treat various illnesses under medical supervision.